NewEdge Advisors, LLC

Position in HIMS — Hims & Hers Health, Inc.

CIK 1633516 NEW ORLEANS, LA

Position in HIMS

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$753,067

-$39,404 QoQ

Shares Held

21,721

-43.1% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#239

of 504 holders

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 9% Shared 0% None 91%

Healthcare · as of Jun 30, 2026

NewEdge Advisors, LLC holds $12,323,215 across 27 Drug Manufacturers - Specialty & Generic names. HIMS ranks #6 (6.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	36,078	$2,592,565
2	NBIX	Neurocrine Biosciences Inc	12,619	$2,126,806
3	UTHR	UNITED THERAPEUTICS Corp	3,861	$2,092,005
4	TEVA	Teva Pharmaceutical Industries Ltd	37,994	$1,287,236
5	HLN	Haleon plc	133,508	$1,245,629
6	HIMS	Hims & Hers Health, Inc. This page	21,721	$753,067
7	VTRS	Viatris Inc	39,976	$634,818
8	COLL	Collegium Pharmaceutical, Inc	16,739	$605,951

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$753,067	21,721	-43.1%	Shares	Sole	2026-08-12
2026-03-31	$792,471	38,173	+25.7%	Shares	Sole	2026-06-03
2025-12-31	$986,211	30,373	-7.9%	Shares	Sole	2026-02-18
2025-09-30	$1,870,171	32,972	-44.4%	Shares	Sole	2025-11-17
2025-06-30	$2,954,908	59,276	+15099.0%	Shares	Sole	2025-08-14
2025-03-31	$11,524	390	-98.1%	Shares	Sole	2025-05-15
2024-12-31	$484,107	20,021	+83.4%	Shares	Sole	2025-02-13
2024-09-30	$201,072	10,916	+2048.8%	Shares	Sole	2024-11-14
2024-06-30	$10,256	508	-95.0%	Shares	Sole	2024-08-16
2021-03-31	$133,623	10,100	—	Shares	Sole	2021-04-26
No filing history on record for this holder in this stock.